ADMA Biologics, Inc. Email Format

Biotechnology ResearchNew Jersey, United States201-500 Employees

ADMA Biologics, Inc. is a biotechnology research and biopharmaceutical company based in Ramsey, New Jersey, with an FDA-licensed plasma fractionation and purification facility in Boca Raton, Florida. It operates as an end-to-end producer and marketer of specialty plasma-derived biologics for immunodeficient patients and others at risk for certain infectious diseases. ADMA markets three FDA-approved plasma-derived immunoglobulin products—BIVIGAM for primary humoral immunodeficiency, ASCENIV for immune deficiencies, and NABI-HB for hepatitis B immune globulin—produced from plasma collected through its ADMA BioCenters subsidiary, an FDA-approved source plasma collection network in the United States. The company holds U.S. patents related to its products and product candidates, including patent numbers 9,107,906; 9,714,283; 9,815,886; 9,969,793; and 10,259,865. ADMA Biologics employs between 201 and 500 people and maintains its website at admabiologics.com.

Sign up for free to view info

Company overview Employee directory